A novel KCNH2 frameshift mutation (c.46delG) associated with high risk of sudden death in a family with congenital long QT syndrome type 2

作者: Hyun Sok Yoo , Nancy Medina , María Alejandra von Wulffen , Natalia Ciampi , Analia Paolucci

DOI: 10.1186/S42444-020-00029-1

关键词:

摘要: The congenital long QT syndrome type 2 is caused by mutations in KCNH2 gene that encodes the alpha subunit of potassium channel Kv11.1. carriers pathogenic variant manifest a phenotype characterized prolongation interval and increased risk sudden cardiac death due to life-threatening ventricular tachyarrhythmias. A family composed 17 members with history recurrent syncopes was studied. DNA proband clinical manifestations analyzed using massive sequencer included following genes: KCNQ1, KCNH2, SCN5A, KCNE1, KCNE2, ANK2, KCNJ2, CACNA1, CAV3, SCN1B, SCN4B, AKAP9, SNTA1, CALM1, KCNJ5, RYR2 TRDN. sequencing identified novel produced heterozygous frameshift mutation c.46delG, pAsp16Thrfs*44 resulting synthesis truncated Kv11.1 ion channel. Eight manifested syndrome. study segregation Sanger revealed identical several positive phenotype. genetic findings this demonstrate causing haploinsufficiency can result severe phenotypic manifestation an elevated death.

参考文章(27)
Ruey J. Sung, Michael R. Lauer, Polymorphic Ventricular Tachycardia and Long QT Syndromes Fundamental Approaches to the Management of Cardiac Arrhythmias. pp. 731- 761 ,(2000) , 10.1007/978-94-011-4371-4_16
Arthur A.M. Wilde, Michael J. Ackerman, Beta-blockers in the treatment of congenital long QT syndrome: is one beta-blocker superior to another? Journal of the American College of Cardiology. ,vol. 64, pp. 1359- 1361 ,(2014) , 10.1016/J.JACC.2014.06.1192
P J Schwartz, A J Moss, G M Vincent, R S Crampton, Diagnostic criteria for the long QT syndrome. An update. Circulation. ,vol. 88, pp. 782- 784 ,(1993) , 10.1161/01.CIR.88.2.782
Silvia G. Priori, Peter J. Schwartz, Carlo Napolitano, Raffaella Bloise, Elena Ronchetti, Massimiliano Grillo, Alessandro Vicentini, Carla Spazzolini, Janni Nastoli, Georgia Bottelli, Roberta Folli, Donata Cappelletti, Risk Stratification in the Long-QT Syndrome The New England Journal of Medicine. ,vol. 348, pp. 1866- 1874 ,(2003) , 10.1056/NEJMOA022147
M. Trudeau, J. Warmke, B Ganetzky, G. Robertson, HERG, a human inward rectifier in the voltage-gated potassium channel family. Science. ,vol. 269, pp. 92- 95 ,(1995) , 10.1126/SCIENCE.7604285
David J. Tester, Michael J. Ackerman, Genetics of long QT syndrome. Methodist DeBakey cardiovascular journal. ,vol. 10, pp. 29- 33 ,(2014) , 10.14797/MDCJ-10-1-29
Peter J. Schwartz, The long QT syndrome Current Problems in Cardiology. ,vol. 22, pp. 297- 351 ,(1997) , 10.1016/S0146-2806(97)80009-6
PETER J. SCHWARTZ, The congenital long QT syndromes from genotype to phenotype: clinical implications. Journal of Internal Medicine. ,vol. 259, pp. 39- 47 ,(2006) , 10.1111/J.1365-2796.2005.01583.X
Peter J. Schwartz, Michael J. Ackerman, Alfred L. George, Arthur A.M. Wilde, Impact of Genetics on the Clinical Management of Channelopathies Journal of the American College of Cardiology. ,vol. 62, pp. 169- 180 ,(2013) , 10.1016/J.JACC.2013.04.044